Status:
COMPLETED
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Healthy
Muscular Dystrophy
Eligibility:
All Genders
Brief Summary
It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with vari...
Detailed Description
It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with vari...
Eligibility Criteria
Patients with skin diseases of presumed genetic, immunologic, or virologic origin are eligible.
Patients with neurological degenerations are eligible, including patients with inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such inherited diseases.
Volunteers without skin diseases are eligible, except children.
Key Trial Info
Start Date :
July 1 1978
Trial Type :
OBSERVATIONAL
End Date :
June 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00001164
Start Date
July 1 1978
End Date
June 1 2000
Last Update
March 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892